The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company's total debt is NZ$100.12 Billion. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2024-12-31 | NZ$106.56 B | 4.3% |
2023-12-31 | NZ$102.17 B | 66.56% |
2022-12-31 | NZ$61.34 B | 25.79% |
2021-12-31 | NZ$48.76 B | 6.67% |
2020-12-31 | NZ$45.71 B | 2.96% |
2019-12-31 | NZ$44.40 B | -12.22% |
2018-12-31 | NZ$50.58 B | 1.65% |
2017-12-31 | NZ$49.76 B | -0.36% |
2016-12-31 | NZ$49.94 B | 8.76% |
2015-12-31 | NZ$45.92 B | 17.14% |
2014-12-31 | NZ$39.20 B | 0.27% |
2013-12-31 | NZ$39.09 B | 21.23% |
2012-12-31 | NZ$32.24 B | 17.46% |
2011-12-31 | NZ$27.45 B | 58.52% |
2010-12-31 | NZ$17.31 B | 18.67% |
2009-12-31 | NZ$14.59 B | -16.77% |
2008-12-31 | NZ$17.53 B | 20.17% |
2007-12-31 | NZ$14.59 B | 14.07% |
2006-12-31 | NZ$12.79 B | 120.96% |
2005-12-31 | NZ$5.78 B | -19.16% |
2004-12-31 | NZ$7.16 B | 51.14% |
2003-12-31 | NZ$4.73 B | -21.8% |
2002-12-31 | NZ$6.05 B | 679.19% |
2001-12-31 | NZ$0.77 B | 6.79% |
2000-12-31 | NZ$0.72 B | 18% |
1999-12-31 | NZ$0.61 B | -1.06% |
1998-12-31 | NZ$0.62 B | 39.75% |
1997-12-31 | NZ$0.44 B | 77.95% |
1996-12-31 | NZ$0.25 B |